Central nervous system disease in phase III studies for advanced HER2 positive breast cancer: A review. [PDF]
Bhogal T, Cameron D, Palmieri C.
europepmc +1 more source
Research progress on phosphodiesterase 4 inhibitors in central nervous system diseases [PDF]
Abudurousuli Adili +3 more
openalex +1 more source
ABSTRACT Neuromyelitis Optica Spectrum Disorder (NMOSD) is a chronic autoimmune neuroinflammatory disease, typically characterized by antibodies against aquaporin 4 (AQP4‐IgG) or myelin oligodendrocyte glycoprotein (MOG‐IgG). Simultaneous seropositivity for both antibodies in a single patient is exceedingly rare.
Yeting Luo, Shuhua Xie, Xianghong Liu
wiley +1 more source
Acquired cervical scoliosis in two dogs with inflammatory central nervous system disease. [PDF]
Poad L, De Decker S, Fenn J.
europepmc +1 more source
Plasma precursor amino acids of central nervous system monoamines in children with coeliac disease. [PDF]
Ángel Hernánz, Isabel Polanco
openalex +1 more source
Increased Blood Levels of NfL, GFAP, and Placental Growth Factor After Radiotherapy to the Brain
ABSTRACT In this study, we analyzed biomarkers of neuronal, glial, and vascular injury in longitudinal paired samples of blood and cerebrospinal fluid after prophylactic cranial irradiation in patients with small cell lung cancer. Neurofilament light chain protein (NfL) and glial fibrillary acidic protein (GFAP) increased in serum and cerebrospinal ...
Erik Fernström +5 more
wiley +1 more source
Cerebrospinal fluid metabolomics: detection of neuroinflammation in human central nervous system disease. [PDF]
Yan J +4 more
europepmc +1 more source
ABSTRACT Objective Status epilepticus (SE) is associated with significant mortality. Sleep architecture may reflect normal brain function. Impaired sleep architecture is associated with poorer outcomes in numerous conditions. Here we investigate the association of sleep architecture in continuous EEG (cEEG) with survival in SE.
Ran R. Liu +5 more
wiley +1 more source
Intranasal delivery of iron chelators and management of central nervous system disease. [PDF]
Cheng R, Kim J.
europepmc +1 more source
Involvement of noncoding RNA in blood-brain barrier integrity in central nervous system disease. [PDF]
Liu X, Shen L, Han B, Yao H.
europepmc +1 more source

